Cross-protection conferred by the vaccine strain Eimeria maxima 013 against six heterologous pathogen strains
Publications
Poultry
The results obtained with regard to protection (reduced oocyst excretion in faeces and reduced macroscopic lesions in the mid-intestine) demonstrate the suitability of the vaccine strain E. maxima 013 for protection against very different field strains.
The study was designed to assess the immunogenicity of the vaccine strain E. maxima 013 when administered in 1-day-old chicks (minimum recommended age for vaccination) against six heterologous pathogen strains from six very different geographic locations.
The results obtained with regard to protection (reduced oocyst excretion in faeces and reduced macroscopic lesions in the mid-intestine) demonstrate the suitability of the vaccine strain E. maxima 013 for protection against very different field strains.
Download this article
Related products
Lyophilisate for oculonasal suspension/use in drinking water.
Active immunisation of pigeons to prevent paramyxovirus infections.
Attenuated vaccine for coccidosis in broilers specifically developed to be administered by in ovo injection.
Live vaccine against Avian Infectious Laryngotracheitis strain CHP50, in oculonasal freeze-dried tablet.
IBD immune-complex vaccine against Infectious Bursal Disease, in injectable suspension
Live vaccine against avian coccidiosis, in oral suspension for spray in chickens
Live vaccine against avian coccidiosis, in oral suspension for spray
Live vaccine against Gumboro disease GM97 strain, in oral freeze-dried tablet
Cloned live vaccine against Gumboro disease, in oral freeze-dried tablet
Live vaccine against Newcastle disease CL/79 clon, in oral freeze-dried tablet
Live vaccine against turkey rhinotracheitis and swollen head syndrome, in oculonasal freeze-dried tablet
Inactivated vaccine against turkey rhinotracheitis and swollen head syndrome, in injectable emulsion
Related services
Get your full poultry vaccination plan encompassing all essential data for avian vaccination.
HIPRA has developed a serial of services englobed under the new GLOBAL HATCHERY HEALTH PROGRAMME (GHHP), the new service for hatcheries that will bring innovation and real-time control of the HEALTH of the hatchery.
Smart Vaccination by HIPRA is a revolutionary concept that combines: A smart vaccine including RFID technology in its label, a vaccination device which ensures precision and efficiency, and a new world of digital solutions in HIPRAlink Vaccination. All these elements are developed internally by HIPRA.
In Poultry, the HIPRA Smart Vaccination is spearheaded by our innovative vaccines GUMBOHATCH®, EVANT® and EVALON® , the medical devices Hipraject® and Hipraspray®, and the professional veterinary app HIPRAlink® Vaccination.
An innovative service based on data analysis that facilitates decision-making in Poultry
HIPRA Stats is a data analysis service for animal production companies.
Hipraspray® is a specific vaccination spray device that ensures accuracy, precision, consistency and reliability.
Hipraject® is an intelligent vaccination device for subcutaneous injection in chicks
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
This programme allows you to calculate the optimal dilution of EVANT® & EVALON® for the best coarse spray administration.
This programme allows you to calculate the optimal vaccination date against IBD (infectious bursal disease)
HIPRA has specially developed several online tools to support veterinarians and other Animal Health professionals in their daily work.
